| 1. |
From the Editor |
| |
Inpharma Weekly,
Volume &NA;,
Issue 947,
1994,
Page 2-2
&NA;,
Preview
|
PDF (751KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 2. |
A green approach to grey matter |
| |
Inpharma Weekly,
Volume &NA;,
Issue 947,
1994,
Page 3-4
Kate Palmer,
Preview
|
PDF (1495KB)
|
|
摘要:
In countries such as India, Japan and China, medicinal plants and herbs have been used to treat CNS disorders for thousands of years. From presentations at the Collegium Internationale Neuro-Psychopharmacologicum (CINP) congress [Washington DC, US; June 1994], it is obvious that there is now increasing interest in plants as a source of CNS-active agents in Western countries.
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 3. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 947,
1994,
Page 4-4
&NA;,
Preview
|
PDF (734KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 4. |
Views in the news- A weekly update on bottom-line conclusions and recommendations from the literature - |
| |
Inpharma Weekly,
Volume &NA;,
Issue 947,
1994,
Page 5-5
&NA;,
Preview
|
PDF (817KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 5. |
Ondansetron prophylaxis - costs outweigh benefits |
| |
Inpharma Weekly,
Volume &NA;,
Issue 947,
1994,
Page 6-6
&NA;,
Preview
|
PDF (734KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 6. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 947,
1994,
Page 7-7
&NA;,
Preview
|
PDF (777KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 7. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 947,
1994,
Page 8-8
&NA;,
Preview
|
PDF (709KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 8. |
Antibody treatment shows efficacy in colorectal cancer without toxicity |
| |
Inpharma Weekly,
Volume &NA;,
Issue 947,
1994,
Page 9-9
Ian Mundell,
Preview
|
PDF (795KB)
|
|
摘要:
An anti-idiotypic antibody treatment for colorectal cancer has demonstrated clinical efficacy equal to that of a common antineoplastic therapy regimen in a trial of 13 patients, but with the added advantage of reduced toxicity. Now plans are underway for a larger, placebo-controlled trial. If successful, it is likely that the New York-based company, ImClone Systems, will rapidly progress commercialisation of the agent. Preliminary work has been conducted at the University of Nottingham, UK; the impressive results are described here.
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 9. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 947,
1994,
Page 10-10
&NA;,
Preview
|
PDF (701KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 10. |
New ‘flu vaccine more immunogenic in the elderly |
| |
Inpharma Weekly,
Volume &NA;,
Issue 947,
1994,
Page 11-11
&NA;,
Preview
|
PDF (710KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
首页
